Skip to main content
. 2025 Oct 21;47:e-rbgo85. doi: 10.61622/rbgo/2025rbgo85

Table 2. Comparison of variables before and after treatment for the estriol group.

Amount of basal and parabasal cells After p-value
≤10 (n=7) >10 (n=8)
Before ≤10 (n=6) 6(40.0) 0(0.0) 1.000a
>10 (n=9) 1(6.7) 8(53.3)
Type of microbiota I (n=4) IIa (n=7) IIb (n=3) III (n=1)
Before I – Presence of only lactobacilli (n=4) 1(6.7) 2(13.3) 1(6.7) 0(0.0) 0.544b
IIa – Presence of other bacteria, but predominance of lactobacilli (n=4) 2(13.3) 2(13.3) 0(0.0) 0(0.0)
IIb – Observation of lactobacilli, but predominance of other bacteria (n=4) 0(0.0) 2(13.3) 1(6.7) 1(6.7)
III – Absence of lactobacilli, presence of only other bacteria (n=3) 1(6.7) 1(6.7) 1(6.7) 0(0.0)
Presence (or absence) of Lactobacillus Absent or rare (n=5) Moderate or numerous (n=10)
Before Absent or rare (n=6) 3(20.0) 3(20.0) 1.000a
Moderate or numerous (n=9) 2(13.3) 7(46.7)
Presence (or absence) of Coccobacillus or bacilli Absent or rare (n=12) Moderate or Numerous (n=3)
Before Absent or rare (n=12) 10(66.7) 2(13.3) 1.000a
Moderate or numerous (n=3) 2(13.3) 1(6.7)
Presence (or absence) of grouped or chained Cocci Absent or rare (n=12) Moderate or Numerous (n=3)
Before Absent or rare (n=12) 10(66.7) 2(13.3) 1.000a
Moderate or numerous (n=3) 2(13.3) 1(6.7)
pH ≥6.1
(n=0)
5.1 – 5.5
(n=4)
4.7 – 5.0
(n=11)
Before ≥6.1 (n=6) 0(0.0) 2(13.3) 4(26.7) 0.006c
5.1–5.5 (n=5) 0(0.0) 2(13.3) 3(20.0)
4.7–5.0 (n=4) 0(0.0) 0(0.0) 4(26.7)
Candida Absent (n=10) Present (n=5)
Before Absent (n=15) 10(66.7) 5(33.3) 0.025c
Present (n=10) 0(0.0) 0(0.0)

Data expressed as frequency (percentage); a McNemar test; b McNemar-Bowker test; c Marginal homogeneity test; pH – Hydrogen potential